More recently Okada et al. [82] demonstrated that miR-34a represses HDM4, a potent negative regulator of TP53, creating positive feedback loop acting on TP53. MiR-34a deficiency alone however does not exhibit a strong oncogenic effect, as confirmed in Kras-induced mouse lung cancer model. Here, TP53 is linked to lung cancer.